These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 32992819)
1. Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs. Moussa Agha D; Rouas R; Najar M; Bouhtit F; Naamane N; Fayyad-Kazan H; Bron D; Meuleman N; Lewalle P; Merimi M Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992819 [TBL] [Abstract][Full Text] [Related]
2. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia. Memari F; Tavakolpour V; Mohajeri N; Poopak B; Fallah P; Alizadeh E; Kouhkan F; Zarghami N Clin Transl Oncol; 2022 Jul; 24(7):1372-1380. PubMed ID: 35247197 [TBL] [Abstract][Full Text] [Related]
3. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia. Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147 [TBL] [Abstract][Full Text] [Related]
4. Integrative proteome analysis of bone marrow interstitial fluid and serum reveals candidate signature for acute myeloid leukemia. Jajula S; Naik V; Kalita B; Yanamandra U; Sharma S; Chatterjee T; Bhanuse S; Bhavsar PP; Taunk K; Rapole S J Proteomics; 2024 Jul; 303():105224. PubMed ID: 38866132 [TBL] [Abstract][Full Text] [Related]
5. miR-582-5p serves as an antioncogenic biomarker in intermediate risk AML with normal cytogenetics and could inhibit proliferation and induce apoptosis of leukemia cells. Wang X; Feng Y; Zhang P; Chen H; Bai J; Wang F; He A Cell Biol Int; 2020 Oct; 44(10):2021-2030. PubMed ID: 32543749 [TBL] [Abstract][Full Text] [Related]
6. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia. Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-206 serves as a tumor suppressor in pediatric acute myeloid leukemia by targeting Cyclin D1. Liu H; Wu H; Qin X Pathol Res Pract; 2019 Oct; 215(10):152554. PubMed ID: 31431298 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia. Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684 [TBL] [Abstract][Full Text] [Related]
9. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia. Wang A; Zhong H Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132 [TBL] [Abstract][Full Text] [Related]
10. Human circulating small non-coding RNA signature as a non-invasive biomarker in clinical diagnosis of acute myeloid leukaemia. Xia L; Guo H; Wu X; Xu Y; Zhao P; Yan B; Zeng Y; He Y; Chen D; Gale RP; Zhang Y; Zhang X Theranostics; 2023; 13(4):1289-1301. PubMed ID: 36923527 [No Abstract] [Full Text] [Related]
11. Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction. Moussa Agha D; Rouas R; Najar M; Bouhtit F; Fayyad-Kazan H; Lagneaux L; Bron D; Meuleman N; Lewalle P; Merimi M Cells; 2020 Sep; 9(9):. PubMed ID: 32911844 [TBL] [Abstract][Full Text] [Related]
12. Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia. Xue Y; Ge Y; Kang M; Wu C; Wang Y; Rong L; Fang Y BMC Cancer; 2019 Jan; 19(1):109. PubMed ID: 30700251 [TBL] [Abstract][Full Text] [Related]
13. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia. Zheng J; Song Y; Li Z; Tang A; Fei Y; He W Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697 [TBL] [Abstract][Full Text] [Related]
14. Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia. Wang W; Wu X; Zheng J; Yin R; Li Y; Wu X; Xu L; Jin Z Front Immunol; 2023; 14():1315453. PubMed ID: 38292478 [TBL] [Abstract][Full Text] [Related]
15. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia. Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118 [TBL] [Abstract][Full Text] [Related]
16. Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia. Lamble AJ; Kosaka Y; Laderas T; Maffit A; Kaempf A; Brady LK; Wang W; Long N; Saultz JN; Mori M; Soong D; LeFave CV; Huang F; Adams H; Loriaux MM; Tognon CE; Lo P; Tyner JW; Fan G; McWeeney SK; Druker BJ; Lind EF Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14331-14341. PubMed ID: 32513686 [TBL] [Abstract][Full Text] [Related]
17. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia. Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional Profiles and Stromal Changes Reveal Bone Marrow Adaptation to Early Breast Cancer in Association with Deregulated Circulating microRNAs. Chiodoni C; Cancila V; Renzi TA; Perrone M; Tomirotti AM; Sangaletti S; Botti L; Dugo M; Milani M; Bongiovanni L; Marrale M; Tripodo C; Colombo MP Cancer Res; 2020 Feb; 80(3):484-498. PubMed ID: 31776132 [TBL] [Abstract][Full Text] [Related]
19. Identification of non-coding RNA regulatory networks in pediatric acute myeloid leukemia reveals circ-0004136 could promote cell proliferation by sponging miR-142. Yuan DM; Ma J; Fang WB Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9251-9258. PubMed ID: 31773676 [TBL] [Abstract][Full Text] [Related]